Global Keratosis Pilaris Treatment Market

Keratosis Pilaris Treatment Comprehensive Study by Type (Rubra, Alba, Rubra Faceii), Treatment (Over-The-Counter, Prescription Medication, Exfoliating, Laser Treatments), Sales Channel (Online Pharmacy, Offline) Players and Region - Global Market Outlook to 2030

Keratosis Pilaris Treatment Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Keratosis Pilaris Treatment
Keratosis pilaris is a very common, harmless skin condition, which hereby causes dry, rough spots as well as tiny bumps, on the upper arms, cheeks, thighs, or buttocks. The bumps usually don't hurt or itch. Keratosis pilaris is often thought of as a variant of normal skin. It cannot be cured or prevented. However, you can treat it with moisturizers and prescription creams to improve the appearance of the skin. The condition usually goes away by the age of 30. A creamy moisturizer can help relieve the itching and dryness. Most moisturizers used to treat keratosis pilaris contain either urea or lactic acid. Keratosis pilaris is most common in families with a history of eczema, allergies, and asthma. About 50 to 80% of teenagers and 40% of adults develop these bumps at some point in their lives. One can usually find these bumps on the upper arms, but they can also appear on cheeks, legs, or buttocks.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Keratosis Pilaris Treatment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Neostrata Company, INC. (United States), Beiersdorf (Germany), Summit Medical Group (United States), Skin Cancer & Dermatology Institute (United States), BioLineRx (Israel), Leo Pharma (Denmark), Alma Lasers (Germany), GlaxoSmithKline (United Kingdom), Leo Pharma (Denmark) and Boehringer Ingelheim (Germany) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Keratosis Pilaris Treatment market by Type (Rubra, Alba and Rubra Faceii) and Region.



On the basis of geography, the market of Keratosis Pilaris Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Over-The-Counter will boost the Keratosis Pilaris Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Online Pharmacy will boost the Keratosis Pilaris Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increase Demand for Laser Therapy and Increasing Adoption of Stronger Cancer Treatments

Market Growth Drivers:
Growing Demand for Number of Drugs for Keratosis Pilaris Treatment by Physicians and Increase Exposure of Solar Radiation

Restraints:
Poor Public Awareness about Keratosis Therapeutics

Opportunities:
Increase in Initiatives in Research & Developments in Dermatologists and Infrastructure Development in Developing Regions

In December 2020, Almirall, S.A., a global biopharmaceutical company focused on skin health, announced that Klisyri (tirbanibulin) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis (AK) of the face or scalp. Klisyri (tirbanibulin) will be launched in the US during the first quarter of 2021.


Key Target Audience
Keratosis Pilaris Treatment Providers, Government Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Rubra
  • Alba
  • Rubra Faceii
By Treatment
  • Over-The-Counter
  • Prescription Medication
  • Exfoliating
  • Laser Treatments

By Sales Channel
  • Online Pharmacy
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Number of Drugs for Keratosis Pilaris Treatment by Physicians
      • 3.2.2. Increase Exposure of Solar Radiation
    • 3.3. Market Trends
      • 3.3.1. Increase Demand for Laser Therapy
      • 3.3.2. Increasing Adoption of Stronger Cancer Treatments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Keratosis Pilaris Treatment, by Type, Treatment, Sales Channel and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Keratosis Pilaris Treatment (Value)
      • 5.2.1. Global Keratosis Pilaris Treatment by: Type (Value)
        • 5.2.1.1. Rubra
        • 5.2.1.2. Alba
        • 5.2.1.3. Rubra Faceii
      • 5.2.2. Global Keratosis Pilaris Treatment by: Treatment (Value)
        • 5.2.2.1. Over-The-Counter
        • 5.2.2.2. Prescription Medication
        • 5.2.2.3. Exfoliating
        • 5.2.2.4. Laser Treatments
      • 5.2.3. Global Keratosis Pilaris Treatment by: Sales Channel (Value)
        • 5.2.3.1. Online Pharmacy
        • 5.2.3.2. Offline
      • 5.2.4. Global Keratosis Pilaris Treatment Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Keratosis Pilaris Treatment (Price)
      • 5.3.1. Global Keratosis Pilaris Treatment by: Type (Price)
  • 6. Keratosis Pilaris Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Neostrata Company, INC. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Beiersdorf (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Summit Medical Group (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Skin Cancer & Dermatology Institute (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioLineRx (Israel)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Leo Pharma (Denmark)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Alma Lasers (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GlaxoSmithKline (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Leo Pharma (Denmark)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Boehringer Ingelheim (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Keratosis Pilaris Treatment Sale, by Type, Treatment, Sales Channel and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Keratosis Pilaris Treatment (Value)
      • 7.2.1. Global Keratosis Pilaris Treatment by: Type (Value)
        • 7.2.1.1. Rubra
        • 7.2.1.2. Alba
        • 7.2.1.3. Rubra Faceii
      • 7.2.2. Global Keratosis Pilaris Treatment by: Treatment (Value)
        • 7.2.2.1. Over-The-Counter
        • 7.2.2.2. Prescription Medication
        • 7.2.2.3. Exfoliating
        • 7.2.2.4. Laser Treatments
      • 7.2.3. Global Keratosis Pilaris Treatment by: Sales Channel (Value)
        • 7.2.3.1. Online Pharmacy
        • 7.2.3.2. Offline
      • 7.2.4. Global Keratosis Pilaris Treatment Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Keratosis Pilaris Treatment (Price)
      • 7.3.1. Global Keratosis Pilaris Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Keratosis Pilaris Treatment: by Type(USD Million)
  • Table 2. Keratosis Pilaris Treatment Rubra , by Region USD Million (2018-2023)
  • Table 3. Keratosis Pilaris Treatment Alba , by Region USD Million (2018-2023)
  • Table 4. Keratosis Pilaris Treatment Rubra Faceii , by Region USD Million (2018-2023)
  • Table 5. Keratosis Pilaris Treatment: by Treatment(USD Million)
  • Table 6. Keratosis Pilaris Treatment Over-The-Counter , by Region USD Million (2018-2023)
  • Table 7. Keratosis Pilaris Treatment Prescription Medication , by Region USD Million (2018-2023)
  • Table 8. Keratosis Pilaris Treatment Exfoliating , by Region USD Million (2018-2023)
  • Table 9. Keratosis Pilaris Treatment Laser Treatments , by Region USD Million (2018-2023)
  • Table 10. Keratosis Pilaris Treatment: by Sales Channel(USD Million)
  • Table 11. Keratosis Pilaris Treatment Online Pharmacy , by Region USD Million (2018-2023)
  • Table 12. Keratosis Pilaris Treatment Offline , by Region USD Million (2018-2023)
  • Table 13. South America Keratosis Pilaris Treatment, by Country USD Million (2018-2023)
  • Table 14. South America Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 15. South America Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 16. South America Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 17. Brazil Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 18. Brazil Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 19. Brazil Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 20. Argentina Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 21. Argentina Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 22. Argentina Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 23. Rest of South America Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 24. Rest of South America Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 25. Rest of South America Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 26. Asia Pacific Keratosis Pilaris Treatment, by Country USD Million (2018-2023)
  • Table 27. Asia Pacific Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 28. Asia Pacific Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 29. Asia Pacific Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 30. China Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 31. China Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 32. China Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 33. Japan Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 34. Japan Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 35. Japan Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 36. India Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 37. India Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 38. India Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 39. South Korea Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 40. South Korea Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 41. South Korea Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 42. Taiwan Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 43. Taiwan Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 44. Taiwan Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 45. Australia Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 46. Australia Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 47. Australia Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 51. Europe Keratosis Pilaris Treatment, by Country USD Million (2018-2023)
  • Table 52. Europe Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 53. Europe Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 54. Europe Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 55. Germany Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 56. Germany Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 57. Germany Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 58. France Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 59. France Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 60. France Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 61. Italy Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 62. Italy Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 63. Italy Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 64. United Kingdom Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 65. United Kingdom Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 66. United Kingdom Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 67. Netherlands Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 68. Netherlands Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 69. Netherlands Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 70. Rest of Europe Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 71. Rest of Europe Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 72. Rest of Europe Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 73. MEA Keratosis Pilaris Treatment, by Country USD Million (2018-2023)
  • Table 74. MEA Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 75. MEA Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 76. MEA Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 77. Middle East Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 78. Middle East Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 79. Middle East Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 80. Africa Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 81. Africa Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 82. Africa Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 83. North America Keratosis Pilaris Treatment, by Country USD Million (2018-2023)
  • Table 84. North America Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 85. North America Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 86. North America Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 87. United States Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 88. United States Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 89. United States Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 90. Canada Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 91. Canada Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 92. Canada Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 93. Mexico Keratosis Pilaris Treatment, by Type USD Million (2018-2023)
  • Table 94. Mexico Keratosis Pilaris Treatment, by Treatment USD Million (2018-2023)
  • Table 95. Mexico Keratosis Pilaris Treatment, by Sales Channel USD Million (2018-2023)
  • Table 96. Keratosis Pilaris Treatment: by Type(USD/Units)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Keratosis Pilaris Treatment: by Type(USD Million)
  • Table 108. Keratosis Pilaris Treatment Rubra , by Region USD Million (2025-2030)
  • Table 109. Keratosis Pilaris Treatment Alba , by Region USD Million (2025-2030)
  • Table 110. Keratosis Pilaris Treatment Rubra Faceii , by Region USD Million (2025-2030)
  • Table 111. Keratosis Pilaris Treatment: by Treatment(USD Million)
  • Table 112. Keratosis Pilaris Treatment Over-The-Counter , by Region USD Million (2025-2030)
  • Table 113. Keratosis Pilaris Treatment Prescription Medication , by Region USD Million (2025-2030)
  • Table 114. Keratosis Pilaris Treatment Exfoliating , by Region USD Million (2025-2030)
  • Table 115. Keratosis Pilaris Treatment Laser Treatments , by Region USD Million (2025-2030)
  • Table 116. Keratosis Pilaris Treatment: by Sales Channel(USD Million)
  • Table 117. Keratosis Pilaris Treatment Online Pharmacy , by Region USD Million (2025-2030)
  • Table 118. Keratosis Pilaris Treatment Offline , by Region USD Million (2025-2030)
  • Table 119. South America Keratosis Pilaris Treatment, by Country USD Million (2025-2030)
  • Table 120. South America Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 121. South America Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 122. South America Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 123. Brazil Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 124. Brazil Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 125. Brazil Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 126. Argentina Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 127. Argentina Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 128. Argentina Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 129. Rest of South America Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 130. Rest of South America Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 131. Rest of South America Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 132. Asia Pacific Keratosis Pilaris Treatment, by Country USD Million (2025-2030)
  • Table 133. Asia Pacific Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 134. Asia Pacific Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 135. Asia Pacific Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 136. China Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 137. China Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 138. China Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 139. Japan Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 140. Japan Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 141. Japan Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 142. India Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 143. India Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 144. India Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 145. South Korea Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 146. South Korea Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 147. South Korea Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 148. Taiwan Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 149. Taiwan Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 150. Taiwan Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 151. Australia Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 152. Australia Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 153. Australia Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 154. Rest of Asia-Pacific Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 155. Rest of Asia-Pacific Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 157. Europe Keratosis Pilaris Treatment, by Country USD Million (2025-2030)
  • Table 158. Europe Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 159. Europe Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 160. Europe Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 161. Germany Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 162. Germany Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 163. Germany Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 164. France Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 165. France Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 166. France Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 167. Italy Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 168. Italy Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 169. Italy Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 170. United Kingdom Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 171. United Kingdom Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 172. United Kingdom Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 173. Netherlands Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 174. Netherlands Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 175. Netherlands Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 176. Rest of Europe Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 177. Rest of Europe Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 178. Rest of Europe Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 179. MEA Keratosis Pilaris Treatment, by Country USD Million (2025-2030)
  • Table 180. MEA Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 181. MEA Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 182. MEA Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 183. Middle East Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 184. Middle East Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 185. Middle East Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 186. Africa Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 187. Africa Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 188. Africa Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 189. North America Keratosis Pilaris Treatment, by Country USD Million (2025-2030)
  • Table 190. North America Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 191. North America Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 192. North America Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 193. United States Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 194. United States Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 195. United States Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 196. Canada Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 197. Canada Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 198. Canada Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 199. Mexico Keratosis Pilaris Treatment, by Type USD Million (2025-2030)
  • Table 200. Mexico Keratosis Pilaris Treatment, by Treatment USD Million (2025-2030)
  • Table 201. Mexico Keratosis Pilaris Treatment, by Sales Channel USD Million (2025-2030)
  • Table 202. Keratosis Pilaris Treatment: by Type(USD/Units)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Keratosis Pilaris Treatment: by Type USD Million (2018-2023)
  • Figure 5. Global Keratosis Pilaris Treatment: by Treatment USD Million (2018-2023)
  • Figure 6. Global Keratosis Pilaris Treatment: by Sales Channel USD Million (2018-2023)
  • Figure 7. South America Keratosis Pilaris Treatment Share (%), by Country
  • Figure 8. Asia Pacific Keratosis Pilaris Treatment Share (%), by Country
  • Figure 9. Europe Keratosis Pilaris Treatment Share (%), by Country
  • Figure 10. MEA Keratosis Pilaris Treatment Share (%), by Country
  • Figure 11. North America Keratosis Pilaris Treatment Share (%), by Country
  • Figure 12. Global Keratosis Pilaris Treatment: by Type USD/Units (2018-2023)
  • Figure 13. Global Keratosis Pilaris Treatment share by Players 2023 (%)
  • Figure 14. Global Keratosis Pilaris Treatment share by Players (Top 3) 2023(%)
  • Figure 15. Global Keratosis Pilaris Treatment share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Neostrata Company, INC. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Neostrata Company, INC. (United States) Revenue: by Geography 2023
  • Figure 19. Beiersdorf (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Beiersdorf (Germany) Revenue: by Geography 2023
  • Figure 21. Summit Medical Group (United States) Revenue, Net Income and Gross profit
  • Figure 22. Summit Medical Group (United States) Revenue: by Geography 2023
  • Figure 23. Skin Cancer & Dermatology Institute (United States) Revenue, Net Income and Gross profit
  • Figure 24. Skin Cancer & Dermatology Institute (United States) Revenue: by Geography 2023
  • Figure 25. BioLineRx (Israel) Revenue, Net Income and Gross profit
  • Figure 26. BioLineRx (Israel) Revenue: by Geography 2023
  • Figure 27. Leo Pharma (Denmark) Revenue, Net Income and Gross profit
  • Figure 28. Leo Pharma (Denmark) Revenue: by Geography 2023
  • Figure 29. Alma Lasers (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Alma Lasers (Germany) Revenue: by Geography 2023
  • Figure 31. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2023
  • Figure 33. Leo Pharma (Denmark) Revenue, Net Income and Gross profit
  • Figure 34. Leo Pharma (Denmark) Revenue: by Geography 2023
  • Figure 35. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Boehringer Ingelheim (Germany) Revenue: by Geography 2023
  • Figure 37. Global Keratosis Pilaris Treatment: by Type USD Million (2025-2030)
  • Figure 38. Global Keratosis Pilaris Treatment: by Treatment USD Million (2025-2030)
  • Figure 39. Global Keratosis Pilaris Treatment: by Sales Channel USD Million (2025-2030)
  • Figure 40. South America Keratosis Pilaris Treatment Share (%), by Country
  • Figure 41. Asia Pacific Keratosis Pilaris Treatment Share (%), by Country
  • Figure 42. Europe Keratosis Pilaris Treatment Share (%), by Country
  • Figure 43. MEA Keratosis Pilaris Treatment Share (%), by Country
  • Figure 44. North America Keratosis Pilaris Treatment Share (%), by Country
  • Figure 45. Global Keratosis Pilaris Treatment: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Neostrata Company, INC. (United States)
  • Beiersdorf (Germany)
  • Summit Medical Group (United States)
  • Skin Cancer & Dermatology Institute (United States)
  • BioLineRx (Israel)
  • Leo Pharma (Denmark)
  • Alma Lasers (Germany)
  • GlaxoSmithKline (United Kingdom)
  • Leo Pharma (Denmark)
  • Boehringer Ingelheim (Germany)
Select User Access Type

Key Highlights of Report


Mar 2024 200 Pages 74 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Keratosis Pilaris Treatment Market Quantitative research analysis
Global Keratosis Pilaris Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Neostrata Company, INC. (United States), Beiersdorf (Germany), Summit Medical Group (United States), Skin Cancer & Dermatology Institute (United States), BioLineRx (Israel), Leo Pharma (Denmark), Alma Lasers (Germany), GlaxoSmithKline (United Kingdom), Leo Pharma (Denmark) and Boehringer Ingelheim (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increase Demand for Laser Therapy " is seen as one of major influencing trends for Keratosis Pilaris Treatment Market during projected period 2023-2030.
The Keratosis Pilaris Treatment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Keratosis Pilaris Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Canine Lymphoma Treatment Comprehensive Study by Drug (Alkylating agents, Corticosteroids, Purine Analogs, Antimetabolites, Immune Modulators, Others), Lymphoma (Multicentric lymphoma, Alimentary lym...
$ 3650
Cardiac Arrest Treatment Comprehensive Study by Application (Hospital, Cardiac Clinics, Ambulatory Surgical Centers), Drug (Vasopressors, Anti-arrhythmic Drugs, Anticholinergic Drugs, Antihypertensiv...
$ 3650
Interstitial Lung Disease Treatment Comprehensive Study by Treatment (Antifibrotics, Corticosteroids, Cytotoxic Drugs, Lung Transplant, Oxygen Therapy, Pulmonary Rehabilitation, Others), End User (Ho...
$ 3350
Prokinetic Drugs Comprehensive Study by Type (Cisapride, Domperidone, Metoclopramide, Levosulpiride, Erythromycin, Tegaserod, Mosapride Citrate, Itopride hydrochloride, Renzapride, Prucalopride), App...
$ 3750
Womens Health Diagnostic Comprehensive Study by Type (Diagnostic Tests, Diagnostic Devices (Biopsy, Imaging, and Monitoring)), Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregn...
$ 3750
Osteoarthritis Therapeutics Comprehensive Study by Type (Primary osteoarthritis, Secondary osteoarthritis), Application (Lifestyle changes. Exercise, Pain relief medicines, Supportive treatments, Sur...
$ 3750